Current Status and Progress in the Treatment of Lower Limb Lymphedema After Treatment of Gynecological Oncology

Author(s):  
He Zhang ◽  
Weimin Kong ◽  
Chao Han ◽  
Tingting Liu ◽  
Jing Li ◽  
...  
2020 ◽  
Vol 16 ◽  
Author(s):  
Ankit Awasthi ◽  
Sachin Kumar Singh ◽  
Bimlesh Kumar ◽  
Monica Gulati ◽  
Rajesh Kumar ◽  
...  

Background: Diabetic foot ulcer (DFU) is one of the leading complications of type-2 diabetes mellitus. It isassociated with neuropathy and peripheral arterial disease of the lower limb in patients with diabetes. Basically, there are four stages of wound healing namely hemostasis phase, inflammatory phase, proliferative phase and maturation phase. In case of DFU, all these stages are disturbed which lead to delay in healing and consequently to lower limb amputation. Traditionally the dosage forms like tablets, creams, ointments, gels and capsules have been used for the treatment of diabetic foot ulcer from many years. Introduction: In this review the global prevalence as well as etiopathogenesis related to diabetic foot ulcer has been discussed. Potential role of various synthetic and herbal drugs as well as their conventional dosage form for the effective management of diabetes foot ulcer has been highlighted. Methods: Structured search of bibliographic databases for previously published peer-reviewed research papers was explored and data was culminated in terms of various approaches that are used for the treatment of diabetic foot ulcer. Results: About 142 papers including both, research and review articles, were included in this review in order to produce a comprehensive as well as readily understandable article. A series of herbal and synthetic drugs have been discussed along with their current status of treatment in terms of dose and mechanism of action. Conclusion: DFU has become one of the most common complications in patients having more than ten years of diabetes. Hence, understanding the root cause and its successful treatment is a big challenge because it depends upon multiple factors such as judicious selection of drug as well as proper control of blood sugar level. Most of the drugs that have been used so far either belong to the category of antibiotics, antihyperglycaemics or, they have been repositioned. Moreover, in clinical practice, much focus has been given towards dressings that have been used to cover the ulcer. The complete treatment of DFU is still a farfetched dream to be achieved and it is expected that a combination therapy of herbal and synthetic drug with multiple treatment pathway could be able to overcome the disease.


Author(s):  
Michael Wong ◽  
Patricia Kay Eaton ◽  
Carla Zanichelli ◽  
Christina Moore ◽  
Catherine Hegarty ◽  
...  

2017 ◽  
Vol 2 (s4) ◽  
pp. 12-19
Author(s):  
Diana Opincariu ◽  
András Mester ◽  
Imre Benedek ◽  
István Benedek

AbstractPeripheral artery diseases include all arterial diseases with the exception of coronary and aortic involvement, more specifically diseases of the extracranial carotids, upper limb arteries, mesenteric and renal vessels, and last but not least, lower limb arteries. Mononuclear stem cells, harvested from various sites (bone marrow, peripheral blood, mesenchymal cells, adipose-derived stem cells) have been studied as a treatment option for alleviating symptoms in peripheral artery disease, as potential stimulators for therapeutic angiogenesis, thus improving vascularization of the ischemic tissue. The aim of this manuscript was to review current medical literature on a novel treatment method — cell therapy, in patients with various peripheral vascular diseases, including carotid, renal, mesenteric artery disease, thromboangiitis obliterans, as well as upper and lower limb artery disease.


2017 ◽  
Vol 96 (3) ◽  
pp. 274-285 ◽  
Author(s):  
Steffen E. Kristensen ◽  
Berit J. Mosgaard ◽  
Mikkel Rosendahl ◽  
Tórur Dalsgaard ◽  
Signe F. Bjørn ◽  
...  

2006 ◽  
Vol 1 (2) ◽  
pp. 126-139 ◽  
Author(s):  
Wesley R. Eby ◽  
Eric Kubica

Lower-limb orthotic devices may be used to aid or restore mobility to the impaired user. Powered orthoses, in particular, hold great potential in improving the quality of life for individuals with locomotor difficulties because active control of an orthosis can aid limb movement in common tasks that may even be impossible if unaided. However, these devices have primarily remained the products of research labs with the number of effective commercial applications for the laity being nearly nonexistent. This paper provides an overview of the current status of powered orthoses and goes on to discuss key issues in modeling and control of powered orthoses so that designers can have a unified framework in developing user-oriented devices. Key concepts are demonstrated for a powered knee-orthosis intended for assisting the sit-to-stand task, and both pneumatic muscle and dc motor actuators are considered in this conceptual design study. In the final analysis, we conclude that the ability to provide sit-to-stand assistance is profoundly dependent on the type of control signal employed to control the actuator from the user–orthosis interface.


Sign in / Sign up

Export Citation Format

Share Document